本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Summit Therapeutics PLC

26.20
-1.4300-5.18%
盤後26.400.2000+0.76%19:58 EDT
成交量:301.07萬
成交額:8,050.20萬
市值:194.58億
市盈率:-77.16
高:28.13
開:27.91
低:26.05
收:27.63
資料載入中...
2020/11/13

重要事件披露

8-K - Current report
2020/11/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/06

重要事件披露

8-K - Current report
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/05

重要事件披露

8-K - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/09/28

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/28

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/18

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/06/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/26

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]